Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Si-Bone (SIBN) Cash from Financing Activities (2017 - 2025)

Historic Cash from Financing Activities for Si-Bone (SIBN) over the last 9 years, with Q3 2025 value amounting to $11000.0.

  • Si-Bone's Cash from Financing Activities fell 9290.32% to $11000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 2116.05%. This contributed to the annual value of $2.0 million for FY2024, which is 9784.68% down from last year.
  • According to the latest figures from Q3 2025, Si-Bone's Cash from Financing Activities is $11000.0, which was down 9290.32% from $2.2 million recorded in Q2 2025.
  • In the past 5 years, Si-Bone's Cash from Financing Activities ranged from a high of $89.1 million in Q2 2023 and a low of -$5.5 million during Q3 2021
  • In the last 5 years, Si-Bone's Cash from Financing Activities had a median value of $601000.0 in 2021 and averaged $5.0 million.
  • As far as peak fluctuations go, Si-Bone's Cash from Financing Activities crashed by 128693.79% in 2021, and later soared by 715166.8% in 2023.
  • Over the past 5 years, Si-Bone's Cash from Financing Activities (Quarter) stood at $1.0 million in 2021, then tumbled by 31.72% to $693000.0 in 2022, then increased by 21.5% to $842000.0 in 2023, then crashed by 109.26% to -$78000.0 in 2024, then skyrocketed by 114.1% to $11000.0 in 2025.
  • Its Cash from Financing Activities stands at $11000.0 for Q3 2025, versus $2.2 million for Q2 2025 and $103000.0 for Q1 2025.